Found: 13
Select item for more details and to access through your institution.
Refined characterization of circulating tumor DNA through biological feature integration.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05606-z
- By:
- Publication type:
- Article
Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 8, p. 1, doi. 10.15252/emmm.202012881
- By:
- Publication type:
- Article
Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 12, p. N.PAG, doi. 10.15252/emmm.201809323
- By:
- Publication type:
- Article
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201707945
- By:
- Publication type:
- Article
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41820-7
- By:
- Publication type:
- Article
Investigating and Correcting Plasma DNA Sequencing Coverage Bias to Enhance Aneuploidy Discovery.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086993
- By:
- Publication type:
- Article
Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients – initial observations.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231884
- By:
- Publication type:
- Article
High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA.
- Published in:
- BMC Medical Genomics, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s12920-015-0107-z
- By:
- Publication type:
- Article
High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA.
- Published in:
- BMC Medical Genomics, 2015, v. 8, n. 1, p. 29, doi. 10.1186/s12920-015-0107-z
- By:
- Publication type:
- Article
ctDNA monitoring using patient-specific sequencing and integration of variant reads.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 548, p. 1, doi. 10.1126/scitranslmed.aaz8084
- By:
- Publication type:
- Article
Enhanced detection of circulating tumor DNA by fragment size analysis.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 466, p. 1, doi. 10.1126/scitranslmed.aat4921
- By:
- Publication type:
- Article
The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection.
- Published in:
- Genome Biology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13059-023-03074-w
- By:
- Publication type:
- Article
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13073-020-00723-8
- By:
- Publication type:
- Article